QLGN קפיטליזציה חשבונאית Qualigen Therapeutics, Inc.

This daily price chart for Qualigen Therapeutics (QLGN) reflects asset dynamics with indicators fixed at 0.00. Qualigen Therapeutics (QLGN) relies on streamlined raw material supply channels and inventory reserves to eliminate disruptions. FastPack technology accelerates the diagnosis of oncology and viruses, providing physicians with real-time data. The diversification of production sites reduces administrative risks, supporting high margins and stable drug distribution.

Book value reflects the net asset value, defined as the difference between all assets and liabilities of a company on a specific date. By analyzing the book value metric on the GURU.Markets platform, an investor can observe the capital accumulation trend, which for Qualigen Therapeutics (QLGN), amid a narrowed R&D pipeline and a lack of imminent breakthroughs, serves as an indicator of financial stability during a period of technological stagnation.